BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31299092)

  • 1. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    Cancer; 2019 Nov; 125(21):3767-3775. PubMed ID: 31299092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
    Liao SH; Su TH; Jeng YM; Liang PC; Chen DS; Chen CH; Kao JH
    Hepatology; 2019 Jan; 69(1):209-221. PubMed ID: 30014620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma.
    Wang JP; Yao ZG; Sun YW; Liu XH; Sun FK; Lin CH; Ren FX; Lv BB; Zhang SJ; Wang Y; Meng FY; Zheng SZ; Gong W; Liu J
    World J Gastroenterol; 2020 Aug; 26(29):4327-4342. PubMed ID: 32848337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.
    Yamashita S; Vauthey JN; Kaseb AO; Aloia TA; Conrad C; Hassan MM; Passot G; Raghav KP; Shama MA; Chun YS
    J Gastrointest Surg; 2016 Oct; 20(10):1725-31. PubMed ID: 27456016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early stage hepatocellular carcinoma in the elderly: A SEER database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
    J Geriatr Oncol; 2017 Jul; 8(4):277-283. PubMed ID: 28389117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and survival for patients with stage-I hepatocellular carcinoma: An observational study based on SEER database.
    Wu Z; Chen W; Ouyang T; Liu H; Cao L
    Medicine (Baltimore); 2020 Oct; 99(41):e22118. PubMed ID: 33031259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis.
    Bitterman DS; Sanford NN; Niemierko A; Mahal BA; Qadan M; Ganguli S; Blaszkowsky LS; Zhu AX; Hong TS; Devlin PM; Goyal L; Wo JY
    Am J Clin Oncol; 2019 Jul; 42(7):564-572. PubMed ID: 31166209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome.
    Zhang C; Feng S; Tu Z; Sun J; Rui T; Zhang X; Huang H; Ling Q; Zheng S
    Cancer Med; 2021 Sep; 10(18):6227-6238. PubMed ID: 34331411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
    Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
    J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis.
    Giannis D; Morsy S; Geropoulos G; Esagian SM; Sioutas GS; Moris D
    In Vivo; 2021; 35(1):393-399. PubMed ID: 33402488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
    Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
    J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Patients with Scirrhous Hepatocellular Carcinoma: Insights from the National Cancer Database.
    Farooq A; Merath K; Paredes AZ; Wu L; Tsilimigras DI; Hyer JM; Sahara K; Mehta R; Beal EW; Pawlik TM
    J Gastrointest Surg; 2020 May; 24(5):1049-1060. PubMed ID: 31243715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.
    Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH
    PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.
    Liu X; Gao H; Zhang J; Xue D
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.